Viral Spike Proteins: Structure, Function, Evolution, and Vaccine Targets

What Are Spike Proteins?

Spike (S) proteins are heavily glycosylated transmembrane glycoproteins that form trimeric protrusions on the surface of many enveloped viruses (coronaviruses, paramyxoviruses, orthomyxoviruses, retroviruses). They mediate host cell attachment and membrane fusion—the critical first steps of infection.

Structure (Coronavirus Prototype: SARS-CoV-2)

  • Trimer: Three S protomers, each ~180 kDa.
  • S1 subunit (receptor-binding): N-terminal domain (NTD) plus receptor-binding domain (RBD). The RBD binds the host receptor (ACE2 for SARS-CoV-2/SARS-CoV; DPP4 for MERS-CoV).
  • S2 subunit (fusion machinery): Fusion peptide (FP), heptad repeats 1 and 2 (HR1, HR2), transmembrane domain (TM), cytoplasmic tail (CT).
  • Cleavage sites: S1/S2 boundary (furin site in SARS-CoV-2 enhances infectivity); S2' (TMPRSS2/cathepsin cleavage) exposes the fusion peptide.
  • Glycan shield: ~66 N-linked glycans per trimer—immune evasion and structural stability.

Functional Cycle

  1. Attachment: S1 RBD binds host receptor, triggering conformational change.
  2. Priming: Host proteases (furin, TMPRSS2, cathepsins) cleave S1/S2 and S2'.
  3. S1 dissociation: Releases S2 for fusion.
  4. Fusion: Fusion peptide inserts into host membrane → HR1/HR2 refold into six-helix bundle → brings viral and cellular membranes together → pore formation → genome release.

Spike Proteins in Major Virus Families

FamilyVirus ExamplesReceptorSpike Name
CoronaviridaeSARS-CoV-2, SARS-CoV, MERS-CoV, HCoV-OC43ACE2, DPP4, 9-O-Ac-SiaS protein
OrthomyxoviridaeInfluenza A/B/C/DSialic acid (α2,6/α2,3)Hemagglutinin (HA)
ParamyxoviridaeMeasles, Nipah, Hendra, RSV, hMPVSLAM, nectin-4, ephrin-B2/3Fusion (F) + Attachment (H/G)
RetroviridaeHIV-1/2CD4 + CCR5/CXCR4Env (gp120/gp41)
FiloviridaeEbola, MarburgNPC1 (after endocytosis)GP

Spike Mutations and Variants

  • Antigenic drift: Mutations in RBD/NTD → immune escape (reduced neutralization by antibodies/vaccines).
  • Enhanced transmissibility: Furin site acquisition (SARS-CoV-2), RBD affinity increases (N501Y), S1/S2 cleavage efficiency.
  • Altered tropism/pathogenicity: D614G (stability, transmissibility); Omicron BA.1/BA.2/BA.5/XBB—extensive RBD changes.
  • Recombination: Template switching during co-infection → chimeric spikes.

Vaccine and Therapeutic Targeting

  • mRNA and adenovector vaccines encode prefusion-stabilized spike (2P mutations) → potent neutralizing antibody response.
  • Monoclonal antibodies (mAbs) target RBD/NTD; vulnerable to escape.
  • Broadly neutralizing antibodies target conserved epitopes (S2 stem helix, fusion peptide).
  • Pan-coronavirus vaccine efforts focus on conserved S2 regions.

Conclusion

Spike proteins are the master keys of viral entry. Their structural plasticity drives immune escape and host adaptation, making them the primary target for vaccines and antivirals—and a moving target for surveillance.

Viral Infections - Related Articles